Flexion Therapeutics

IPO

Local therapies for musculoskeletal conditions

Burlington, United States · Founded 2007 · $53.0M raised

Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$53.0M
Last Round
$20.0M Series BJan 2010
Rounds
2

About

Flexion Therapeutics (NASDAQ: FLXN) was a biopharmaceutical company focused on the discovery, development, and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, with a primary focus on osteoarthritis pain. The company developed ZILRETTA, an extended-release corticosteroid injection for osteoarthritis knee pain. Founded in 2007 and headquartered in Burlington, Massachusetts, Flexion was acquired by Pacira BioSciences in November 2021 for approximately $630 million, strengthening Pacira's non-opioid pain management portfolio.

Summary

Flexion Therapeutics is a Biotech company based in Burlington, United States, founded in 2007. It has raised $53.0M in total across 2 rounds, most recently a $20.0M Series B round in Jan 2010. Investors include Versant Ventures, Novo Capital and 5AM Ventures.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOFeb 2014
$74.8M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Flexion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/flexion-therapeutics"><img src="https://indexed.vc/api/badge/company/flexion-therapeutics" alt="Flexion Therapeutics on Indexed.vc" width="260" height="76" /></a>